Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two ...

Black people in the US are not only more likely than other folks to get eczema in childhood, but may have harder-to-treat or ...

Results of a retrospective real-world study suggested no greater risk for major CV adverse events in patients treated with ...

A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential ...

As previously reported in Women’s Health, semaglutide injections mimic the effects of a hormone called glucagon-like ...